Evidence map›Paper›PMID 33808496›Full record

ReviewInternational journal of molecular sciences2021

Artificial Intelligence in Aptamer-Target Binding Prediction.

Zihao Chen, Long Hu, Bao-Ting Zhang, Aiping Lu, Yaofeng Wang, Yuanyuan Yu, Ge Zhang

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Cell SELEX-based DNA aptamer selection targetingVeterinary research forum : an international quarterly journal · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. In silico development of RNA aptamer candidates against thyroid receptor.Journal of computer-aided molecular design · 2025
    Article
  17. Review
  18. Review
  19. Advantages, applications, and future directions ofMolecular therapy. Nucleic acids · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zihao ChenSchool of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0002-7690-8651
Long HuLaw Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Bao-Ting ZhangSchool of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Aiping LuInstitute of Integrated Bioinformedicine and Translational Science, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Yaofeng WangCentre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong, China.
Yuanyuan YuLaw Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Ge ZhangLaw Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.ORCID 0000-0002-7807-7695

Funding

Basic and Applied Basic Research Fund from Department of Science and Technology of Guangdong Province 2019B1515120089Hong Kong General Research Fund from the Research Grants Council of the Hong Kong Special Administrative Region, China 12102120Inter-institutional Collaborative Research Scheme from Hong Kong Baptist University RC-ICRS/19-20/01National Key R&D Program from the Ministry of Science and Technology of China 2018YFA0800800Theme-based Research Scheme from the Research Grants Council of the Hong Kong Special Administrative Region, China T12-201/20-R
6 · The paper itself

Abstract

Aptamers are short single-stranded DNA, RNA, or synthetic Xeno nucleic acids (XNA) molecules that can interact with corresponding targets with high affinity. Owing to their unique features, including low cost of production, easy chemical modification, high thermal stability, reproducibility, as well as low levels of immunogenicity and toxicity, aptamers can be used as an alternative to antibodies in diagnostics and therapeutics. Systematic evolution of ligands by exponential enrichment (SELEX), an experimental approach for aptamer screening, allows the selection and identification of in vitro aptamers with high affinity and specificity. However, the SELEX process is time consuming and characterization of the representative aptamer candidates from SELEX is rather laborious. Artificial intelligence (AI) could help to rapidly identify the potential aptamer candidates from a vast number of sequences. This review discusses the advancements of AI pipelines/methods, including structure-based and machine/deep learning-based methods, for predicting the binding ability of aptamers to targets. Structure-based methods are the most used in computer-aided drug design. For this part, we review the secondary and tertiary structure prediction methods for aptamers, molecular docking, as well as molecular dynamic simulation methods for aptamer-target binding. We also performed analysis to compare the accuracy of different secondary and tertiary structure prediction methods for aptamers. On the other hand, advanced machine-/deep-learning models have witnessed successes in predicting the binding abilities between targets and ligands in drug discovery and thus potentially offer a robust and accurate approach to predict the binding between aptamers and targets. The research utilizing machine-/deep-learning techniques for prediction of aptamer-target binding is limited currently. Therefore, perspectives for models, algorithms, and implementation strategies of machine/deep learning-based methods are discussed. This review could facilitate the development and application of high-throughput and less laborious in silico methods in aptamer selection and characterization.

Indexed as

Aptamers, NucleotideArtificial IntelligenceComputer-Aided DesignComputer SimulationForecastingLigandsMolecular Docking SimulationNucleic AcidsReproducibility of ResultsSELEX Aptamer TechniqueAptamers, NucleotideLigandsNucleic Acidsaptamerartificial intelligencebindingdeep learningmachine learningSELEXstructure prediction

Identifiers

PMID33808496
PMCPMC8038094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.